2-{4-[(TERT-BUTYL)OXYCARBONYL]PIPERAZINYL}-2-(2-THIENYL)ACETIC ACID, 95.0%, 1g

Methyl 6-amino-4-chloronicotinate, 97.0%, 5g

(3-hydroxy-1-adamantyl)acetic acid, 95.0%, 25g

2-PYRAZINECARBOXAMIDE, 5-[2-METHOXY-4-[[[2-(TETRAHYDRO-2H-PYRAN-4-YL)ETHYL]AMINO]METHYL]PHENOXY]-, 95.0%, 1g

6-Iodo-1-methyl-1H-indazole, 95.0%, 1g

2,2'-(9,9-Dioctyl-9h-fluorene-2,7-diyl)bis(1,3,2-dioxaborinane), 98%, 5g

1-Bromo-2-naphthaldehyde, 98.0%, 5g

Pipettes Pasteur seringues ultra fines sans graduation, 3,5 ml, stériles, individuelles, 157 mm, 400 pièces

(E)-6-(4-methoxyphenyl)hex-5-en-1-ol, 95%, 250mg

2-Vinylthiophene, 97.0%, 10g

2-(4-((3-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

2,5-Dihydroxybenzoic Acid [Matrix for MALDI-TOF/MS]>99.0%(GC)(T)1g

N-Chloroacetyl-D-phenylalanine>98.0%(T)1g